卡博替尼继发的获得性反应性穿通性胶原病：一例报告及文献复习
Acquired reactive perforating collagenosis secondary to Cabozantinib: A case report and literature review.
作者信息
Rehan Zahra, Haner Andrea, Taleb Amina, Ikeri Nzechukwu, Hardin Jori
机构信息
Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
The Jack Ady Cancer Centre, Lethbridge, AB, Canada.
出版信息
SAGE Open Med Case Rep. 2024 Dec 16;12:2050313X241304961. doi: 10.1177/2050313X241304961. eCollection 2024.
Acquired perforating dermatoses (APD) encompass a group of skin conditions distinguished by transepidermal elimination of dermal components. Acquired reactive perforating collagenosis (ARPC), a subtype of APD, has been reported most commonly in association with diabetes mellitus, chronic renal failure, and medications. In this report, we identify a novel case of ARPC secondary to Cabozantinib treatment.
获得性穿通性皮肤病（APD）是一组以真皮成分经表皮排出为特征的皮肤疾病。获得性反应性穿通性胶原病（ARPC）是APD的一种亚型，最常报道与糖尿病、慢性肾衰竭及药物有关。在本报告中，我们发现了一例继发于卡博替尼治疗的ARPC新病例。
Zotero 插件